Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.2513 per EA under NDC 69315016601. Its NADAC has been published 303 times since Nov 4, 2020.
FDA first approved this application on Feb 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Clomipramine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315016601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211364FDA Approved
2/7/2020
TE Code
AB
On Market Since
3/10/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 303 times since Nov 4, 2020, and over the history we have for it it has declined 91.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2513 per EA |
|---|---|
| All-time high | $2.8927 (Nov 11, 2020) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.3369 |
| Average price | $0.6760 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 303 |
| Tracking since | Nov 4, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.2513 per EA (NDC 69315016601), effective Aug 19, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 91.3%. It has been tracked across 303 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Nov 4, 2020, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $2.8927 (Nov 11, 2020), with a median of $0.3369 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 69315016601) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.